Status:
COMPLETED
Immune Adsorption Role in Treatment of Resistant Lupus
Lead Sponsor:
Dr. Mohamed Ahmed El ghiriani
Conditions:
Systemic Lupus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: lupus is a heterogeneous autoimmune disease with autoantibodies formation. Lupus nephritis carries the worst prognosis. C1q deficiency correlates with activity and renal involvement and ma...
Detailed Description
Settings and design: A controlled clinical study was conducted on group A, sixty patients with lupus in activity subdivided into cases 1, 47 patients, who received traditional medical treatment and ca...
Eligibility Criteria
Inclusion
- systemic lupus erythematosus in activity
Exclusion
- End stage renal disease, other renal replacement therapy
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 25 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04108611
Start Date
January 1 2019
End Date
September 25 2019
Last Update
October 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Alexandria University
Alexandria, Sidi Beshr, Egypt, 21624